Shockwave Medical Inc (SWAV)
330.88
+0.01
(+0.00%)
USD |
NASDAQ |
May 16, 16:00
330.82
-0.06
(-0.02%)
After-Hours: 20:00
Shockwave Medical Research and Development Expense (TTM): 163.14M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 163.14M |
| December 31, 2023 | 145.65M |
| September 30, 2023 | 127.05M |
| June 30, 2023 | 107.70M |
| March 31, 2023 | 91.63M |
| December 31, 2022 | 81.68M |
| September 30, 2022 | 72.67M |
| June 30, 2022 | 66.23M |
| March 31, 2022 | 57.29M |
| December 31, 2021 | 50.54M |
| September 30, 2021 | 44.87M |
| Date | Value |
|---|---|
| June 30, 2021 | 39.03M |
| March 31, 2021 | 35.31M |
| December 31, 2020 | 36.93M |
| September 30, 2020 | 37.96M |
| June 30, 2020 | 38.43M |
| March 31, 2020 | 37.26M |
| December 31, 2019 | 32.85M |
| September 30, 2019 | 28.90M |
| June 30, 2019 | 26.06M |
| March 31, 2019 | 24.67M |
| December 31, 2018 | 22.70M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
26.06M
Minimum
Jun 2019
163.14M
Maximum
Mar 2024
66.06M
Average
47.71M
Median
Research and Development Expense (TTM) Benchmarks
| Boston Scientific Corp | 1.444B |
| AtriCure Inc | 78.43M |
| Masimo Corp | 172.50M |
| Tactile Systems Technology Inc | 7.733M |
| RxSight Inc | 29.87M |